In Vitro BE Study in ANDA Drug Product Development

In this podcast, we talk about an in vitro bioequivalence (BE) Study in ANDA drug development with a special guest: Dr. Kang Wang, Vice President of Analytical Services at Frontage Laboratories, Inc.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

This field is for validation purposes and should be left unchanged.

In Vitro BE Study in ANDA Drug Product Development

Resources to Consider

IN Vitro Assessment of the inhibition of Human Organic Anion...

In Vitro ADME Services

Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption

Nonclinical Vehicle Formulations:HP-β-CD...

An Unexpected Major Circulating Metabolite M219 Detected in...

A Hybrid Trial Approach by Combining 13C8-Lableded & Radiolabeled...

Testing of Carryover & After MRD Benchtop Stability for...

Liquid Biopsy: Challenges and benefits of cell-free DNA sequencing

Best Practices in Managing IND Programs with CROs

Relative Bioavailability Study of Colchicine Oral Solution and...

Accurate Mass: The Best Solution For Metabolite Identification In...

Dr. Song Li, Frontage’s Founder, Ringing The Bell Of The Hong Kong...